The MoH said on January 5that the council decided to submit the proposal after making thorough and carefulconsideration of opinions from specialised units and experts.
To strictly control medicinequality, the council requested that manufacturers examine material qualitybefore production; continue monitoring and examining drug quality on a monthlybasis after receiving the certificates and present reports to relevant authorisedagencies; and continue studying the medicines’ stability and submit researchfindings and expiry date updates to serve assessment as in accordance with theASEAN Common Technical Dossier.
Regarding the authorisation ofCOVID-19 medicine circulation, the Minister of Health asked managerial andspecialised agencies to keep a strict control of quality and prices as in linewith the Law on Pharmacy and to fight against any negative phenomenon and groupinterest in medicine supply./.